These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 6086697)

  • 21. Hormonal therapy of prostate cancer.
    Labrie F
    Prog Brain Res; 2010; 182():321-41. PubMed ID: 20541672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of serum prolactin on plasma adrenal androgens and the production and metabolic clearance rate of dehydroepiandrosterone sulfate in normal and hyperprolactinemic subjects.
    Schiebinger RJ; Chrousos GP; Cutler GB; Loriaux DL
    J Clin Endocrinol Metab; 1986 Jan; 62(1):202-9. PubMed ID: 2999177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partial androgen suppression consequent to increased secretion of adrenal androgens in a patient with prostate cancer treated with long-acting GnRH agonists.
    Spitz IM; Chertin B; Fridmans A; Farkas A; Belanger A; Hartman H; Labrie F
    Prostate Cancer Prostatic Dis; 2009; 12(1):100-3. PubMed ID: 18574491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ACTH stimulation tests and plasma dehydroepiandrosterone sulfate levels in women with hirsutism.
    Siegel SF; Finegold DN; Lanes R; Lee PA
    N Engl J Med; 1990 Sep; 323(13):849-54. PubMed ID: 2168515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients.
    Miyazawa Y; Sekine Y; Syuto T; Nomura M; Koike H; Matsui H; Shibata Y; Ito K; Suzuki K
    BMC Urol; 2017 Aug; 17(1):70. PubMed ID: 28851333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adrenal androgen response to metyrapone, adrenocorticotropin, and corticotropin-releasing hormone stimulation in children with hypopituitarism.
    Pang SY; Legido A; Levine LS; Temeck JW; New MI
    J Clin Endocrinol Metab; 1987 Aug; 65(2):282-9. PubMed ID: 3036902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous administration of pure antiandrogens, a combination necessary for the use of luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer.
    Labrie F; Dupont A; Bélanger A; Emond J; Monfette G
    Proc Natl Acad Sci U S A; 1984 Jun; 81(12):3861-3. PubMed ID: 6427777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lower testosterone levels with luteinizing hormone-releasing hormone agonist therapy than with surgical castration: new insights attained by mass spectrometry.
    van der Sluis TM; Bui HN; Meuleman EJ; Heijboer AC; Hartman JF; van Adrichem N; Boevé E; de Ronde W; van Moorselaar RJ; Vis AN
    J Urol; 2012 May; 187(5):1601-6. PubMed ID: 22425112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adrenal suppression with aminoglutethimide. III. Comparison of plasma delta 4- and delta 5-steroids in postmenopausal women treated for breast carcinoma.
    Samojlik E; Santen RJ
    J Clin Endocrinol Metab; 1978 Oct; 47(4):717-24. PubMed ID: 162517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacology of an antiandrogen, anandron, used as an adjuvant therapy in the treatment of prostate cancer.
    Moguilewsky M; Fiet J; Tournemine C; Raynaud JP
    J Steroid Biochem; 1986 Jan; 24(1):139-46. PubMed ID: 3009970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adrenocorticotropic hormone is involved in regulation of androgen synthesis in men receiving androgen deprivation therapy for localized prostate cancer.
    Takizawa I; Hara N; Nishiyama T; Isahaya E; Hoshii T; Takahashi K
    J Urol; 2010 Nov; 184(5):1971-6. PubMed ID: 20884032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adrenocorticotropin-stimulated adrenal androgen secretion in anorexia nervosa: impaired secretion at low weight with normalization after long-term weight recovery.
    Winterer J; Gwirtsman HE; George DT; Kaye WH; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1985 Oct; 61(4):693-7. PubMed ID: 2993344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Orchiectomy does not selectively increase adrenal androgen concentrations.
    Parker L; Lai M; Wolk F; Lifrak E; Kim S; Epstein L; Hadley D; Miller J
    J Clin Endocrinol Metab; 1984 Sep; 59(3):547-50. PubMed ID: 6235240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Marked attenuation of ultradian and circadian rhythms of dehydroepiandrosterone in postmenopausal women: evidence for a reduced 17,20-desmolase enzymatic activity.
    Liu CH; Laughlin GA; Fischer UG; Yen SS
    J Clin Endocrinol Metab; 1990 Oct; 71(4):900-6. PubMed ID: 2169480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of spironolactone on adrenal steroidogenesis in hirsute women.
    Serafini P; Lobo RA
    Fertil Steril; 1985 Nov; 44(5):595-9. PubMed ID: 2996951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levels of plasma steroid glucuronides in intact and castrated men with prostatic cancer.
    Bélanger A; Brochu M; Cliche J
    J Clin Endocrinol Metab; 1986 May; 62(5):812-5. PubMed ID: 2937801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Castration plus nilutamide vs castration plus placebo in advanced prostate cancer. A review.
    Du Plessis DJ
    Urology; 1991; 37(2 Suppl):20-4. PubMed ID: 1992599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of flutamide on pituitary and adrenal responsiveness to corticotrophin releasing factor (CRF).
    De Leo V; la Marca A; Lanzetta D; Cariello PL; D'Antona D; Morgante G
    Clin Endocrinol (Oxf); 1998 Jul; 49(1):85-9. PubMed ID: 9797851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Keyrole of endocrinology in the victory against prostate cancer].
    Labrie F
    Bull Cancer; 2006 Sep; 93(9):949-58. PubMed ID: 16980238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deficiency in androgens and upregulation of insulin-like growth factor-1 are involved in high bone turnover in men receiving androgen deprivation therapy for prostate cancer.
    Ishizaki F; Hara N; Takizawa I; Nishiyama T; Isahaya E; Kawasaki T; Takahashi K
    Growth Horm IGF Res; 2012; 22(3-4):122-8. PubMed ID: 22579549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.